TY - JOUR
T1 - Association of changes in cardiovascular health levels with incident cardiovascular events and mortality in patients with atrial fibrillation
AU - Cho, Seunghoon
AU - Yang, Pil Sung
AU - Kim, Daehoon
AU - You, Seng Chan
AU - Sung, Jung Hoon
AU - Jang, Eunsun
AU - Yu, Hee Tae
AU - Kim, Tae Hoon
AU - Pak, Hui Nam
AU - Lee, Moon Hyoung
AU - Joung, Boyoung
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
PY - 2023/6
Y1 - 2023/6
N2 - Background: Risk factor management is crucial in the management of atrial fibrillation (AF). We investigated the association of changes in cardiovascular health (CVH) levels after AF diagnosis with incident cardiovascular events and mortality. Methods: From the Korea National Health Insurance Service database, 76,628 patients newly diagnosed with AF (2005–2015) with information on health examinations before and after AF diagnosis were assessed. According to the change in the 12-point CVH score before and after AF diagnosis, patients were stratified into four groups: consistently low (score 0–7 to 0–7), high-to-low (8–12 to 0–7), low-to-high (0–7 to 8–12), and consistently high (8–12 to 8–12) CVH levels. Risks of cardiovascular events and death were analyzed using weighted Cox regression models with inverse probability of treatment weighting (IPTW) for balance across study groups. Results: The mean age of study participants was 58.3 years, 50,285 were men (63.1%), and the mean follow-up was 5.5 years. After IPTW, low-to-high (hazard ratio [95% confidence interval], 0.83 [0.76–0.92]) and consistently high (0.80 [0.74–0.87]) CVH levels were associated with a lower risk of ischemic stroke than consistently low CVH. Low-to-high (0.66 [0.52–0.84]) and consistently high (0.52 [0.42–0.64]) CVH levels were associated with a lower risk of acute myocardial infarction. Maintaining high CVH was associated with reduced risks of heart failure hospitalization (0.85 [0.75–0.95]) and all-cause death (0.82 [0.77–0.88]), respectively, compared with consistently low CVH. Conclusions: Improving CVH levels and maintaining high CVH levels after AF diagnosis is associated with lower risks of subsequent cardiovascular events and mortality. Graphical abstract: [Figure not available: see fulltext.].
AB - Background: Risk factor management is crucial in the management of atrial fibrillation (AF). We investigated the association of changes in cardiovascular health (CVH) levels after AF diagnosis with incident cardiovascular events and mortality. Methods: From the Korea National Health Insurance Service database, 76,628 patients newly diagnosed with AF (2005–2015) with information on health examinations before and after AF diagnosis were assessed. According to the change in the 12-point CVH score before and after AF diagnosis, patients were stratified into four groups: consistently low (score 0–7 to 0–7), high-to-low (8–12 to 0–7), low-to-high (0–7 to 8–12), and consistently high (8–12 to 8–12) CVH levels. Risks of cardiovascular events and death were analyzed using weighted Cox regression models with inverse probability of treatment weighting (IPTW) for balance across study groups. Results: The mean age of study participants was 58.3 years, 50,285 were men (63.1%), and the mean follow-up was 5.5 years. After IPTW, low-to-high (hazard ratio [95% confidence interval], 0.83 [0.76–0.92]) and consistently high (0.80 [0.74–0.87]) CVH levels were associated with a lower risk of ischemic stroke than consistently low CVH. Low-to-high (0.66 [0.52–0.84]) and consistently high (0.52 [0.42–0.64]) CVH levels were associated with a lower risk of acute myocardial infarction. Maintaining high CVH was associated with reduced risks of heart failure hospitalization (0.85 [0.75–0.95]) and all-cause death (0.82 [0.77–0.88]), respectively, compared with consistently low CVH. Conclusions: Improving CVH levels and maintaining high CVH levels after AF diagnosis is associated with lower risks of subsequent cardiovascular events and mortality. Graphical abstract: [Figure not available: see fulltext.].
KW - Atrial fibrillation
KW - Cardiovascular disease
KW - Cardiovascular health
KW - Cardiovascular risk factors
KW - Mortality
UR - http://www.scopus.com/inward/record.url?scp=85134302998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134302998&partnerID=8YFLogxK
U2 - 10.1007/s00392-022-02058-3
DO - 10.1007/s00392-022-02058-3
M3 - Article
C2 - 35829750
AN - SCOPUS:85134302998
SN - 1861-0684
VL - 112
SP - 724
EP - 735
JO - Clinical Research in Cardiology
JF - Clinical Research in Cardiology
IS - 6
ER -